Applied Clinical Education (ACE) develops educational initiatives designed to meet the needs of practicing clinicians based on identified and verifiable gaps within a target audience. Individual activities focus on maintaining, developing, or increasing the knowledge, skills, and professional performance of clinicians to advance care.

As an advocate of lifelong learning and supporter of applied learning strategies, ACE is dedicated to providing education that strengthens medical knowledge and enhances the clinical care of patients by healthcare professionals with the ultimate goal of improving patient care and public health.

ACE hosts the medical education Web sites CMEZone.com and CEZone.com. All educational activities jointly sponsored by ACE, regardless of primary distribution, have an E-CME component posted online at CMEZone.com/CEZone.com. Through its partnership with CECity, ACE makes all CME/CPE/CE activities available to CECity’s Centricity Network, which consists of more than 35 sites devoted to medical professions. This alliance further extends the reach of education for ACE activities.

ACE maintains a strong relationship with McMahon Publishing’s 12 specialty publications, which consistently reach more than 450,000 clinicians. For over 35 years, McMahon Publishing has built and maintained a strong track record of excellent readership scores for these vehicles, with several publications achieving best-read status according to syndicated readership surveys. With a combination of editorial excellence, frequent communications with its network of readers, and a presence at approximately 85 medical conventions each year, McMahon Publishing offers an unparalleled educational distribution and dissemination channel to clinicians across the United States—a channel that is uniquely available to ACE.

With its partnership with McMahon Publishing’s specialty publications, and the even broader audience afforded by its E-CME arms, ACE effectively delivers CME/CPE/CE activities to large audiences of appropriate clinicians.

Biologics and Biosimilars in Colorectal Cancer

Learning Objectives At the completion of this activity, participants should be better able to: 1. Describe the molecular pathways and genetic mutations implicated in mCRC. 2. Review data for the efficacy and safety of current biologic agents for the treatment of mCRC. 3. Discuss the definitions, data, and regulatory landscape around the development of oncologic biosimilars.
Applied Clinical Education

Can Deep Neuromuscular Blockade Optimize Patient Safety and Surgical Outcomes?

Learning Objectives Upon completion of this activity, participants will have improved their ability to: 1. Identify surgeries for which deep neuromuscular blockade (NMB) can optimize patient outcomes 2. Discuss the risks and benefits of deep NMB with surgical suite colleagues 3. Recognize the prevalence and clinical consequences of residual NMB 4. Identify patients with increased risk of ...
Applied Clinical Education

Deep Neuromuscular Block, Patient Safety, and Enhanced Recovery: Which Patients and What Procedures?

Learning Objectives Upon completion of this activity, participants will have improved their ability to: Identify surgeries for which deep neuromuscular block will improve patient safety and outcomes Review the role of residual neuromuscular blockade on surgical outcomes Assess the potential role of complete reversal of deep neuromuscular blockade in enhanced recovery pathways Deve...
Applied Clinical Education

Metastatic Prostate Cancer: Current Trends and Future Landscape

Learning Objectives: At the completion of this activity, participants should be better able to: 1. Communicate with patients and colleagues about the pathophysiology, risk factors, symptoms, and genetics of prostate cancer. 2. Create individualized treatment plans for patients with prostate cancer based on current screening and staging guidelines and evidence for monotherapy, combinatio...
Applied Clinical Education

Preventing Residual Neuromuscular Blockade and Ensuring Complete Recovery: A Discussion and Demonstration Using Simulation

Upon completion of this activity, participants will have improved their ability to: 1. Identify patients at risk for residual neuromuscular blockade (RNMB) 2. Appraise the roles of subjective and objective train-of-four monitoring in reducing the risk of RNMB 3. Employ an appropriate RNMB reversal agent and dose in patients with comorbid conditions 4. Discuss strategies to improve perioper...
Applied Clinical Education

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.